Literature DB >> 25232431

Relation between radiographic BI-RADS scores and triple negativity in patients with ductal carcinomas.

Murat Oktay1, Nilay Aydın Oktay2, Fahri Halit Besir2, Ramazan Buyukkaya2, Havva Erdem1, Binnur Onal3, Ismet Ozaydın4, Burhan Yazıcı2.   

Abstract

UNLABELLED: The aim of this study was to investigate association of radiographic (BI-RADS 4 and 5) results and prognostic factors of invasive ductal carcinomas with their histopathological subtypes. A total of 103 patients histopathologically diagnosed with invasive ductal carcinoma of breast with in last five years period were enrolled. Of them, 69 patients who had radiological reports in were included from registry of Radiology Department; Duzce University Training and Research Hospital archives. BI-RADS scores (4 and 5) of radiological reports and subtypes of ductal carcinoma were compared. Of 69 cases, 12 of 22 cases with BIRADS 4 score were Triple negative (TN) while 5 of 47 cases with BIRADS 5 score were TN (p = 0.001). The patients with TN tumors were found to have lower average age, higher grade, higher Ki67 proliferative index and fewer lymph node metastasis than those with non-TN ductal carcinomas (p = 0.048; 0.019; 0.02; 0.048 respectively).
CONCLUSIONS: Patients who had radiological BIRADS 4 score were significantly more frequent TN type carcinoma than BI-RADS 5. It is important to pay attention to this issue when clinicians evaluate patients with BI-RADS 4 score breast lesions.

Entities:  

Keywords:  BI-RADS score; Breast; subtypes of ductal carcinoma; triple negative

Year:  2014        PMID: 25232431      PMCID: PMC4161591     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  19 in total

1.  Pathologic assessment of non-palpable probably benign breast masses at sonography: can instant intervention be avoided and is follow-up adequate?

Authors:  C Yücesoy; N Aydin Oktay; E Oztürk; M Oktay; S Hücümenoğlu; M Alper; B Hekimoğlu
Journal:  JBR-BTR       Date:  2010 Sep-Oct

2.  Can the radiologist accurately predict the adequacy of sampling when performing ultrasound-guided core biopsy of BI-RADS category 4 and 5 lesions detected on screening mammography?

Authors:  J M Doyle; A O'Doherty; L Coffey; S Pender; A Hill; C Quinn
Journal:  Clin Radiol       Date:  2005-09       Impact factor: 2.350

Review 3.  Molecular subtypes in breast cancer evaluation and management: divide and conquer.

Authors:  Jeffrey Peppercorn; Charles M Perou; Lisa A Carey
Journal:  Cancer Invest       Date:  2008-02       Impact factor: 2.176

4.  Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.

Authors:  Yurdanur Sullu; Guzin G Demirag; Arzu Yildirim; Filiz Karagoz; Bedri Kandemir
Journal:  Pathol Res Pract       Date:  2011-10-24       Impact factor: 3.250

5.  Triple-negative breast cancers: unique clinical presentations and outcomes.

Authors:  Julie A Y Billar; Amylou C Dueck; Chee-Chee H Stucky; Richard J Gray; Nabil Wasif; Donald W Northfelt; Ann E McCullough; Barbara A Pockaj
Journal:  Ann Surg Oncol       Date:  2010-09-19       Impact factor: 5.344

6.  Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.

Authors:  Wei-Tse Yang; Mark Dryden; Kristine Broglio; Michael Gilcrease; Shaheenah Dawood; Peter J Dempsey; Vicente Valero; Gabriel Hortobagyi; Deann Atchley; Banu Arun
Journal:  Breast Cancer Res Treat       Date:  2007-11-17       Impact factor: 4.872

7.  Triple-negative breast cancer: correlation between imaging and pathological findings.

Authors:  Eun Sook Ko; Byung Hee Lee; Hyun-A Kim; Woo-Chul Noh; Min Suk Kim; Sang-Ah Lee
Journal:  Eur Radiol       Date:  2009-11-07       Impact factor: 5.315

8.  Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound.

Authors:  Eun Bi Ryu; Jung Min Chang; Mirinae Seo; Sun Ah Kim; Ji He Lim; Woo Kyung Moon
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

9.  Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.

Authors:  A Goldhirsch; W C Wood; A S Coates; R D Gelber; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2011-06-27       Impact factor: 32.976

10.  Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.

Authors:  Stefano Calza; Per Hall; Gert Auer; Judith Bjöhle; Sigrid Klaar; Ulrike Kronenwett; Edison T Liu; Lance Miller; Alexander Ploner; Johanna Smeds; Jonas Bergh; Yudi Pawitan
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.